PERINATAL OUTCOMES ASSOCIATED WITH SUBCHORIONIC HEMATOMA AND LOW-DOSE ASPIRIN IN WOMEN OF EARLY GESTATION

Retrochorial hematoma is a pathology of the first trimester of pregnancy, leading to complications of perinatal outcomes. Low doses of aspirin improve blood flow in early gestation, helping to reduce perinatal outcomes.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-06
DOI
https://doi.org/10.5281/zenodo.14825735
Primary Topic
Gestational Trophoblastic Disease Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PERINATAL OUTCOMES ASSOCIATED WITH SUBCHORIONIC HEMATOMA AND LOW-DOSE ASPIRIN IN WOMEN OF EARLY GESTATION

Zenodo (CERN European Organization for Nuclear Research)
Gestational Trophoblastic Disease Studies
article

PERINATAL OUTCOMES ASSOCIATED WITH SUBCHORIONIC HEMATOMA AND LOW-DOSE ASPIRIN IN WOMEN OF EARLY GESTATION

article en

Abstract

Retrochorial hematoma is a pathology of the first trimester of pregnancy, leading to complications of perinatal outcomes. Low doses of aspirin improve blood flow in early gestation, helping to reduce perinatal outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 40%
Gestational Trophoblastic Disease Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

PERINATAL OUTCOMES ASSOCIATED WITH SUBCHORIONIC HEMATOMA AND LOW-DOSE ASPIRIN IN WOMEN OF EARLY GESTATION · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS